Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SANDOZ

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 45
  • 0 comments

FDA approve OMEPRAZOLE

Comment Full text

SANDOZ

  • FDA Approval
  • Oct. 16, 2023, 11:50 UTC
  • 31
  • 0 comments

FDA approve OMEPRAZOLE

Comment Full text

LAURUS LABS LTD

  • FDA Approval
  • Oct. 13, 2023, 11:46 UTC
  • 46
  • 0 comments

FDA approve DOLUTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Oct. 13, 2023, 11:46 UTC
  • 42
  • 0 comments

FDA approve FINASTERIDE

Comment Full text

ALEMBIC PHARMS LTD

  • FDA Approval
  • Oct. 13, 2023, 11:46 UTC
  • 43
  • 0 comments

FDA approve SELEXIPAG

Comment Full text

ZHEJIANG YONGTAI

  • FDA Approval
  • Oct. 13, 2023, 11:46 UTC
  • 41
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Oct. 13, 2023, 11:46 UTC
  • 44
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

ARRAY BIOPHARMA INC

  • FDA Approval
  • Oct. 13, 2023, 11:46 UTC
  • 41
  • 0 comments

FDA approve ENCORAFENIB

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Oct. 13, 2023, 11:46 UTC
  • 40
  • 0 comments

FDA approve FOSAPREPITANT DIMEGLUMINE

Comment Full text

ACTAVIS LABS FL INC

  • FDA Approval
  • Oct. 13, 2023, 11:46 UTC
  • 47
  • 0 comments

FDA approve BUDESONIDE

Comment Full text
  • Previous
  • 658
  • 659
  • 660
  • 661
  • 662
  • Next

Search

News categories

  • Technical Exchange News(11989)
  • Event(5035)
  • SEC News(247713)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148936)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin